Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination.
批准号:
10163555
负责人:
Rafick Pierre Sekaly
金额:
$31.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-29 至
关键词:
Administrative SupplementBiologicalBiological AssayCOVID-19ClinicalClinical DataCohort StudiesDataDisease ProgressionGoalsImageImmune System DiseasesImmune responseImmunophenotypingInfectionIrrigationKnowledgeLaboratoriesLeadershipNatural ImmunityOhioPennsylvaniaPeripheral Blood Mononuclear CellPhenotypeReadingSamplingSpecimenSputumStandardizationTestingUniversitiesVaccinationViral PathogenesisViruscohortcoronavirus diseasehelminth infectionimmunological statusprogramssample collection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary:
The goal of the Administrative Supplement is to provide a central rich store of data and specimens
from two independent cohorts located in Reading, Pennsylvania and Cleveland, Ohio. The
samples and the clinical data will be distributed to the central cores assigned by the program
where standardized phenotypic assays will be performed. General leadership of the Cores will be
provided by Dr. Charles Cairns from Drexel University for the Reading cohort and Dr. Benigno
from Case Western Reserve University.
There are 3 aims of this Administrative supplement.
Specific Aim 1: To provide biological specimens (PBMCs, sputum, and lavages) to all our
designated cores in order to characterize the immunophenotypes and the immune status and
response to COVID-19 infection.
Specific Aim 2: To provide clinical data (CBC counts, clinical tests, imaging) to all our designated
cores in order to establish correlation with immune status and disease progression
Specific Aim 3: To provide biological specimens and clinical data to our assigned laboratories at
Drexel and Case Western Universities. These laboratories will perform unique assays that are not
covered by the core laboratories of the program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MultiOMICS mechanistic identification of predictors of HIV DNA decay, restoration of immune homeostasis and HIV specific immunity in PWH with cancer receiving Immune check point therapy
-
批准号:10731665
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10588314
-
项目类别:
-
资助金额:$79.33万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
-
批准号:10731661
-
项目类别:
-
资助金额:$129.39万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
MOIR - Administrative Core
-
批准号:10731662
-
项目类别:
-
资助金额:$9.62万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
I2 Control= Modulating Innate Immunity to Achieve Control of HIV
-
批准号:10731664
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2023
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10429404
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2022
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Emory/Georgia TB Research Advancement Center (TRAC)
-
批准号:10596182
-
项目类别:
-
资助金额:$8.72万
-
财政年份:2022
-
负责人:Rafick Pierre Sekaly
-
依托单位:
A multi-tiered approach to develop validated assays to predict efficacy of a tetravalent live attenuated Dengue Virus vaccine in Phase II and Phase III clinical trials
-
批准号:10341373
-
项目类别:
-
资助金额:$104.7万
-
财政年份:2021
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10222321
-
项目类别:
-
资助金额:$79.55万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir
-
批准号:10321500
-
项目类别:
-
资助金额:$74.39万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
OMICs to define impact of cocaine on immunity and HIV persistence in treated HIV infection
-
批准号:10321501
-
项目类别:
-
资助金额:$53.2万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10680632
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2020
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Core C - Modeling Core
-
批准号:10080706
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:9623814
-
项目类别:
-
资助金额:$87.52万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10198704
-
项目类别:
-
资助金额:$154.03万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Core C - Modeling Core
-
批准号:10322684
-
项目类别:
-
资助金额:$40.56万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:9979743
-
项目类别:
-
资助金额:$63.67万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10336870
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
-
批准号:10463861
-
项目类别:
-
资助金额:$76.96万
-
财政年份:2018
-
负责人:Rafick Pierre Sekaly
-
依托单位:
Resetting immune homeostasis: a non-invasive approach towards HIV eradication
-
批准号:10303927
-
项目类别:
-
资助金额:$134.71万
-
财政年份:2017
-
负责人:Rafick Pierre Sekaly
-
依托单位:
海外基金